Personalized mRNA Vaccine Shows Promise Against Pancreatic CancerApril 21, 2025 Promising results from a personalized cancer vaccine trial show patients who developed an immune response remain cancer-free after three years
Corporation BioVaxys to Present at Emerging Growth ConferenceFebruary 25, 2025 BioVaxys Technology Corp. will present at the Emerging Growth Conference on January 16, 2025, offering investors and analysts a real-time interactive session with the company’s leadership.
